logo

For the Inventor, By the Inventor

Cardiff, United Kingdom

Rsr Limited


USPTO Granted Patents = 30

% Expired Patents = 16.7


Trademarks = 2

Forward Citations = 128

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Jadwiga Furmaniak (20 out of 20 patents)

silverMedal Bernard Rees Smith (18 out of 18 patents)

bronzeMedal Jane Sanders (15 out of 15 patents)

4.  Raymond D Prengaman (7 out of 9 patents)

5.  Michael Powell (4 out of 4 patents)

6.  Herschel B McDonald (3 out of 3 patents)

7.  Bernard Rees-Smith (2 out of 2 patents)

8.  Clifford E Morgan (2 out of 3 patents)

9.  James Howard (1 out of 15 patents)

10.  R David Prengaman (1 out of 10 patents)

11.  Barnard Rees Smith (1 out of 1 patent)

12.  Peter John Burne (1 out of 1 patent)

13.  Gerald M Griffin, Jr (1 out of 1 patent)

14.  Homer P Hine (1 out of 1 patent)

15.  Jadwiga Maria Furmaniak-Wehr (1 out of 1 patent)


Core Competencies:
Glycoprotein Hormone Receptor
Autoantibodies
Thyrotropin Receptor
Monoclonal Antibodies
Crystal Structure
Autoimmune Disease
Lead-Acid Batteries
Electrowinning
Antagonists
Binding Partners
Diagnosis
Assays

30 patents:

1. 11732026 - Glycoprotein hormone receptor mutations (2023-08-22),
2. 10488410 - Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin (2019-11-26),
3. 10481156 - Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin (2019-11-19),
4. 10428153 - Human anti TSHR antibodies (2019-10-01),
5. 9751940 - Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto (2017-09-05),
6. 9435797 - Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin (2016-09-06),
7. 9147036 - Crystal structure (2015-09-29),
8. 9073992 - Human anti TSHR antibodies (2015-07-07),
9. 9046519 - Mutated thyrotropin receptor (2015-06-02),
10. 8900823 - Binding partners for the thyrotropin receptor and uses thereof (2014-12-02),
11. 8840891 - Human monoclonal antibodies to the thyrotropin receptor which act as antagonists (2014-09-23),
12. 8753637 - Binding partners for the thyrotropin receptor and uses thereof (2014-06-17),
13. 8309693 - Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto (2012-11-13),
14. 8298771 - Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto (2012-10-30),
15. 8298769 - Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto (2012-10-30),
Company Overview
Rsr Limited, based in Cardiff, specializes in the development and manufacturing of advanced electronic systems and components. The company focuses on delivering innovative solutions across various sectors, including telecommunications, automotive, and industrial applications. With a commitment to research and technology, Rsr Limited aims to enhance performance and efficiency through cutting-edge engineering practices. Their expertise in electronic design and system integration positions them as a key player in the evolving landscape of technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

30 Patents

#3 in Cardiff

#595 in United Kingdom

#21,912 in the World

Cardiff, GB
Cardiff, United Kingdom

Rsr Limited

Forward Citations = 128

16 inventors:

goldMedal Jadwiga Furmaniak (20 out of 20 patents)

silverMedal Bernard Rees Smith (18 out of 18 patents)

bronzeMedal Jane Sanders (15 out of 15 patents)

4.  Raymond D Prengaman (7 out of 9 patents)

5.  Michael Powell (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rsr Limited. Retrieved from https://idiyas.com/company/rsr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…